Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Suzanne B. Zane is active.

Publication


Featured researches published by Suzanne B. Zane.


Obstetrics & Gynecology | 2004

Risk factors for legal induced abortion-related mortality in the United States.

Linda Bartlett; Cynthia J. Berg; Holly B. Shulman; Suzanne B. Zane; Clarice A. Green; Sara Whitehead; Hani K. Atrash

OBJECTIVE: To assess risk factors for legal induced abortion–related deaths. METHODS: This is a descriptive epidemiologic study of women dying of complications of induced abortions. Numerator data are from the Abortion Mortality Surveillance System. Denominator data are from the Abortion Surveillance System, which monitors the number and characteristics of women who have legal induced abortions in the United States. Risk factors examined include age of the woman, gestational length of pregnancy at the time of termination, race, and procedure. Main outcome measures include crude, adjusted, and risk factor–specific mortality rates. RESULTS: During 1988–1997, the overall death rate for women obtaining legally induced abortions was 0.7 per 100,000 legal induced abortions. The risk of death increased exponentially by 38% for each additional week of gestation. Compared with women whose abortions were performed at or before 8 weeks of gestation, women whose abortions were performed in the second trimester were significantly more likely to die of abortion-related causes. The relative risk (unadjusted) of abortion-related mortality was 14.7 at 13–15 weeks of gestation (95% confidence interval [CI] 6.2, 34.7), 29.5 at 16–20 weeks (95% CI 12.9, 67.4), and 76.6 at or after 21 weeks (95% CI 32.5, 180.8). Up to 87% of deaths in women who chose to terminate their pregnancies after 8 weeks of gestation may have been avoidable if these women had accessed abortion services before 8 weeks of gestation. CONCLUSION: Although primary prevention of unintended pregnancy is optimal, among women who choose to terminate their pregnancies, increased access to surgical and nonsurgical abortion services may increase the proportion of abortions performed at lower-risk, early gestational ages and help further decrease deaths. LEVEL OF EVIDENCE: II-2


Obstetrics & Gynecology | 2011

Trends in Ectopic Pregnancy Mortality in the United States: 1980-2007

Andreea A. Creanga; Carrie K. Shapiro-Mendoza; Connie L. Bish; Suzanne B. Zane; Cynthia J. Berg; William M. Callaghan

OBJECTIVE: To estimate trends in ectopic pregnancy mortality and examine characteristics of recently hospitalized women who died as a result of ectopic pregnancy in the United States. METHODS: We used 1980–2007 national birth and death certificate data to calculate ectopic pregnancy mortality ratios (deaths per 100,000 live births) overall and stratified by maternal age and race. We performed nonparametric tests for trend to assess changes in ectopic pregnancy mortality over time and calculated projected mortality ratios for 2013–2017. Ectopic pregnancy deaths among hospitalized women were identified from 1998–2007 Nationwide Inpatient Sample data. RESULTS: Between 1980 and 2007, 876 deaths were attributed to ectopic pregnancy. The ectopic pregnancy mortality ratio declined by 56.6%, from 1.15 to 0.50 deaths per 100,000 live births between 1980–1984 and 2003–2007; at the current average annual rate of decline, this ratio will further decrease by 28.5% to 0.36 ectopic pregnancy deaths per 100,000 live births by 2013–2017. The ectopic pregnancy mortality ratio was 6.8 times higher for African Americans than whites and 3.5 times higher for women older than 35 years than those younger than 25 years during 2003–2007. Of the 76 deaths among women hospitalized between 1998 and 2007, 70.5% were tubal pregnancies; salpingectomy was performed in 80.6% of cases. Excessive hemorrhage, shock, or renal failure accompanied 67.4% of ectopic pregnancy deaths among hospitalized women. CONCLUSION: Despite a significant decline in ectopic pregnancy mortality since the 1980s, age disparities, and especially racial disparities, persist. Strategies to ensure timely diagnosis and management of ectopic pregnancies can further reduce related mortality and age and race mortality gaps.


Obstetrics & Gynecology | 2007

Toxic Shock Associated With Clostridium sordellii and Clostridium perfringens After Medical and Spontaneous Abortion

Adam L. Cohen; Julu Bhatnagar; Sarah Reagan; Suzanne B. Zane; Marisa A. D'Angeli; Marc Fischer; George Killgore; Tao Kwan-Gett; David B. Blossom; Wun Ju Shieh; Jeannette Guarner; John A. Jernigan; Jeffrey S. Duchin; Sherif R. Zaki; L. Clifford McDonald

OBJECTIVE: To better understand the risk of fatal toxic shock caused by Clostridium sordellii in women who had a recent medical abortion with mifepristone and misoprostol. METHODS: We performed active and passive surveillance for cases of toxic shock associated with medical or spontaneous abortion. To identify the cause of toxic shock, immunohistochemical assays for multiple bacteria were performed on formalin-fixed surgical and autopsy tissues. We extracted DNA from tissues, performed Clostridium species–specific polymerase chain reaction assays, and sequenced amplified products for confirmation of Clostridium species. RESULTS: We report four patients with toxic shock associated with Clostridium species infection after medical or spontaneous abortion. Two women had fatal Clostridium perfringens infections after medically induced abortions: one with laminaria and misoprostol and one with the regimen of mifepristone and misoprostol. One woman had a nonfatal Clostridium sordellii infection after spontaneous abortion. Another woman had a fatal C sordellii infection after abortion with mifepristone and misoprostol. All four patients had a rapidly progressive illness with necrotizing endomyometritis. CONCLUSION: Toxic shock after abortion can be caused by C perfringens as well as C sordellii, can be nonfatal, and can occur after spontaneous abortion and abortion induced by medical regimens other than mifepristone and misoprostol. LEVEL OF EVIDENCE: III


Clinical Infectious Diseases | 2003

Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory

Timothy M. Uyeki; Suzanne B. Zane; Ulana R. Bodnar; Katherine Fielding; Jane A. Buxton; Joy M. Miller; Michael Beller; Jay C. Butler; Keiji Fukuda; Susan A. Maloney; Martin S. Cetron

We investigated a large summertime outbreak of acute respiratory illness during May-September 1998 in Alaska and the Yukon Territory, Canada. Surveillance for acute respiratory illness (ARI), influenza-like illness (ILI), and pneumonia conducted at 31 hospital, clinic, and cruise ship infirmary sites identified 5361 cases of ARI (including 2864 cases of ILI [53%] and 171 cases of pneumonia [3.2%]) occurring primarily in tourists and tourism workers (from 18 and 37 countries, respectively). Influenza A viruses were isolated from 41 of 210 patients with ILI at 8 of 14 land sites and 8 of 17 cruise ship infirmaries. Twenty-two influenza isolates were antigenically characterized, and all were influenza A/Sydney/05/97-like (H3N2) viruses. No other predominant pathogens were identified. We estimated that >33,000 cases of ARI might have occurred during this protracted outbreak, which was attributed primarily to influenza A/Sydney/05/97-like (H3N2) viruses. Modern travel patterns may facilitate similar outbreaks, indicating the need for increased awareness about influenza by health care providers and travelers and the desirability of year-round influenza surveillance in some regions.


Maternal and Child Health Journal | 2002

Surveillance in a time of changing health care practices: estimating ectopic pregnancy incidence in the United States.

Suzanne B. Zane; A Burney KiekeJr.; Juliette S. Kendrick; Carol Bruce

Objectives: Ectopic pregnancy is a common condition with significant health consequences; complications are a major cause of maternal mortality in the United States. Accurate ascertainment of the number of ectopic pregnancies occurring in the United States has been dramatically affected by changing medical practices, causing estimates based on hospital data to be falsely low. This study was performed to identify nationally representative data on ectopic pregnancies and determine overlap of these data, to calculate the annual weighted number of ectopic pregnancies and confidence intervals for these estimates, and to determine barriers to estimation of ectopic pregnancy incidence. Methods: To assess whether a national estimate of the incidence of ectopic pregnancy could be calculated, we analyzed 1992–99 data from the six nationally representative data sets that include information on ectopic pregnancy. We examined relevant data in each data set and assessed whether any combination of data sets could be used to estimate ectopic pregnancy incidence. We calculated weighted estimates and 95% confidence intervals for hospitalizations, outpatient surgeries, outpatient medical procedures, and physician visits for and self-reports of ectopic pregnancy. Results: Small sample sizes severely limited calculation of estimates of ectopic pregnancy. Data needed for assessing multiple counting was not available consistently. The likelihood of multiple counting of cases was substantial when data set counts were combined. Conclusions: A reliable incidence rate for ectopic pregnancy in the United States could not be estimated from existing nationally representative data sources. Major advances in diagnosis and treatment of ectopic pregnancy have affected surveillance in two ways: inpatient hospital treatment of ectopic pregnancy has decreased, and multiple health care visits for a single ectopic pregnancy have increased. Alternate means of surveillance are needed to improve understanding of risk factors and trends for ectopic pregnancy, and we recommend examination of the databases of public and private insurance systems and managed care systems. Similar alternate means of surveillance may be needed for other health conditions with comparable changes in management of care.


Obstetrics & Gynecology | 2015

Abortion-Related Mortality in the United States: 1998-2010.

Suzanne B. Zane; Andreea A. Creanga; Cynthia J. Berg; Karen Pazol; Danielle B. Suchdev; Denise J. Jamieson; William M. Callaghan

OBJECTIVE: To examine characteristics and causes of legal induced abortion–related deaths in the United States between 1998 and 2010. METHODS: Abortion-related deaths were identified through the national Pregnancy Mortality Surveillance System with enhanced case-finding. We calculated the abortion mortality rate by race, maternal age, and gestational age and the distribution of causes of death by gestational age and procedure. RESULTS: During the period from 1998–2010, of approximately 16.1 million abortion procedures, 108 women died, for a mortality rate of 0.7 deaths per 100,000 procedures overall, 0.4 deaths for non-Hispanic white women, 0.5 deaths for Hispanic women, and 1.1 deaths for black women. The mortality rate increased with gestational age, from 0.3 to 6.7 deaths for procedures performed at 8 weeks or less and at 18 weeks or greater, respectively. A majority of abortion-related deaths at 13 weeks of gestation or less were associated with anesthesia complications and infection, whereas a majority of abortion-related deaths at more than 13 weeks of gestation were associated with infection and hemorrhage. In 20 of the 108 cases, the abortion was performed as a result of a severe medical condition where continuation of the pregnancy threatened the womans life. CONCLUSION: Deaths associated with legal induced abortion continue to be rare events—less than 1 per 100,000 procedures. Primary prevention of unintended pregnancy, including those in women with serious pre-existing medical conditions, and increased access to abortion services at early gestational ages may help to further decrease abortion-related mortality in the United States. LEVEL OF EVIDENCE: III


American Journal of Obstetrics and Gynecology | 2009

Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age

Christine S. Ho; Julu Bhatnagar; Adam L. Cohen; Jill K. Hacker; Suzanne B. Zane; Sarah Reagan; Marc Fischer; Wun-Ju Shieh; Jeannette Guarner; Shabbir Ahmad; Sherif R. Zaki; L. Clifford McDonald

OBJECTIVE In 2005, 4 Clostridium sordellii-associated toxic shock fatalities were reported in young Californian women after medical abortions. The true incidence of this rare disease is unknown, and a population-based study has never been performed. Additional clostridia-associated deaths were sought to describe associated clinical characteristics. STUDY DESIGN Population-based death certificate review and a clinical case definition for clostridial-associated toxic shock identified women with likelihood of dying from a Clostridium infection. Formalin-fixed autopsy tissues underwent immunohistochemical and polymerase chain reaction assays. RESULTS Thirty-eight women were suspected of having C sordellii-associated death. Five tested positive for Clostridium species: 3 for Clostridium perfringens, 1 for C sordellii, and 1 for both. Deaths occurred after the medical procedures for cervical dysplasia (n = 2), surgical abortion (n = 1), stillborn delivery (n = 1), and term live birth (n = 1). None had a medical abortion. CONCLUSION C sordellii and C perfringens are associated with undiagnosed catastrophic infectious gynecologic illnesses among women of childbearing age.


Current Infectious Disease Reports | 2011

Gynecologic Clostridial Toxic Shock in Women of Reproductive Age

Suzanne B. Zane; Jeannette Guarner

Clostridial toxic shock, caused by Clostridium sordellii or Clostridium perfringens, is a rare and largely fatal syndrome among reproductive-aged women with genital tract infection, and may occur following various pregnancy outcomes or without pregnancy. Clinicians should be aware of common clinical features of this very rapidly-progressing syndrome including abdominal pain, tachycardia, hypotension, third-space fluid accumulations, hemoconcentration, and marked leukemoid response, often with lack of fever. In this review, we summarize known cases through mid-2011 and information on clinical presentation, diagnosis, treatment, and results of recent investigations regarding pathogenesis, including germination, toxins, and host response that may have important implications for development of preventive or therapeutic interventions.


Contraception | 2012

Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001–2008

Karen Pazol; Andreea A. Creanga; Suzanne B. Zane

BACKGROUND With changing patterns and increasing use of medical abortion in the United States, it is important to have accurate statistics on the use of this method regularly available. This study assesses the accuracy of medical abortion data reported annually to the Centers for Disease Control and Prevention (CDC) and describes trends over time in the use of medical abortion relative to other methods. STUDY DESIGN This analysis included data reported to CDC for 2001-2008. Year-specific analyses included all states that monitored medical abortion for a given year, while trend analyses were restricted to states that monitored medical abortion continuously from 2001 to 2008. Data quality and completeness were assessed by (a) examining abortions reported with an unspecified method type within the gestational age limit for medical abortion (med-eligible abortions) and (b) comparing the percentage of all abortions and med-eligible abortions reported to CDC as medical abortions with estimates based on published mifepristone sales data for the United States from 2001 to 2007. RESULTS During 2001-2008, the percentage of med-eligible abortions reported to CDC with an unspecified method type remained low (1.0%-2.2%); CDC data and mifepristone sales estimates for 2001-2007 demonstrated strong agreement [all abortions: intraclass correlation coefficient (ICC)=0.983; med-eligible abortions: ICC=0.988]. During 2001-2008, the percentage of abortions reported to CDC as medical abortions increased (p<.001 for all abortions and for med-eligible abortions). Among states that reported medical abortions for 2008, 15% of all abortions and 23% of med-eligible abortions were reported as medical abortions. CONCLUSION CDCs Abortion Surveillance System provides an important annual data source that accurately describes the use of medical abortion relative to other methods in the United States.


Journal of herpetological medicine and surgery | 2003

Reducing Transmission of Salmonella From Reptiles to Zoo Patrons: A Cross-Sectional Study of Zoos and Aquariums in the United States

Stephanie Wong; Cindy R. Friedman; Suzanne B. Zane; Frederick J. Angulo

ABSTRACT Purpose: An estimated 70,000 cases of human salmonellosis are attributed to contact with reptiles each year in the United States. In response to a reptile-associated outbreak of salmonellosis at a large metropolitan zoo in 1996, the Centers for Disease Control and Prevention (CDC) conducted a survey of American Zoo and Aquarium Association (AZA) institutional members to determine the knowledge, attitudes and practices of zoo and aquarium personnel regarding Salmonella and reptiles. Research design: This cross-sectional survey was conducted in 1996 via a 31-item, closed-ended questionnaire faxed to all AZA institutions. Results: Of the 176 institutions listed in the AZA directory, 123 (70%) responded. Of the 109 responding AZA institutions that met the survey inclusion criteria, 78 (72%) allowed direct contact between exhibit reptiles and patrons. While 62 (78%) of the institutions instructed patrons to wash their hands after reptile contact, 57 (52%) of the institutions did not have hand-washing ...

Collaboration


Dive into the Suzanne B. Zane's collaboration.

Top Co-Authors

Avatar

Wilda Y. Parker

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Cynthia J. Berg

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Karen Pazol

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Lilo T. Strauss

United States Department of Health and Human Services

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joy L. Herndon

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Linda Bartlett

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Denise J. Jamieson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Hani K. Atrash

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge